Navigation Links
Study shows rise in antibiotic resistant pediatric head and neck infections
Date:1/19/2009

Highlights

  • Prevalence of antibiotic-resistant head and neck infections is increasing.
  • There is growing concern in the medical community about an epidemic of community acquired antibiotic resistant infections.
  • Clinicians must be judicious in prescribing antibiotics.

ATLANTA A report by researchers in the Jan. 19, 2009 Archives of Otolaryngology-Head and Neck Surgery shows that there was nationwide increase in the prevalence of pediatric methicillin-resistant Staphylococcus aureus (MRSA) head and neck infections from January 2001 to December 2006.

The increase in antibiotic-resistant infections has become a big concern for researchers and clinicians over the years. MRSA was once a condition that was only found in hospital settings; however, over the last decade MRSA outbreaks have increasingly been found in patients without risk factors.

In an attempt to identify trends in the susceptibility of antibiotic-resistant infections, researchers from Emory University School of Medicine and Children's Healthcare of Atlanta studied data on pediatric patients from nationwide hospitals.

"The growing concern about the recent worldwide MRSA epidemic has fueled the curiosity of the scientific community to gain insight into the clinical and epidemiologic manifestations of this microbe," says Steven E. Sobol, MD, MSc, primary investigator of the study and director of Pediatric Otolaryngology in the Department of Otolaryngology - Head and Neck Surgery at Emory.

"Previous studies have established that skin and soft tissue infections in some communities are due to MRSA," he says. "However, it has been observed in several institutions that there is a significant rise in pediatric head and neck infections as well."

The researchers reviewed a total of 21,009 pediatric head and neck S. aureus infections from 300 hospitals nationwide that occurred between Jan. 1, 2001 and Dec. 31, 2006. Patients ranged in ages from birth to 18.

In 2001, approximately 12 percent of all isolated S. aureus in the study was methicillin resistant. During the following five years, the number steadily rose to more than 28 percent. Overall during those six years there was a 16.3 percent increase in the percentage of resistance for all pediatric head and neck S. aureus infections.

"There is a nationwide increase in the prevalence of MRSA in children with head and neck infections that is alarming," says Sobol. "Clinicians must use antibiotic agents judiciously in order to reduce further antimicrobial drug resistance."

Sobol suggests that there be careful testing of suspected head and neck infections, leading to more appropriate antimicrobial drug selection. He also recommends further studies to gain additional insight into this organism.

Additional study investigators include Iman Naseri, MD, formerly of Emory's Department of OtolaryngologyHead and Neck Surgery and Robert C. Jerris, PhD, Children's Healthcare of Atlanta.

This study was supported by a grant from Alcon Laboratories Inc.

Reference: Nationwide Trends in Pediatric Staphylococcus aureus Head and Neck Infections, Archives of Otolaryngology Head and Neck Surgery/Vol 135 (No. 1): 14-16


'/>"/>

Contact: Kathi Baker
kobaker@emory.edu
404-727-9371
Emory University
Source:Eurekalert

Related medicine news :

1. Study: Growth in research comes at a steep price
2. National Childrens Study Begins Recruiting
3. A Study In This Months Journal Of Nervous And Mental Disease Reveals Hope For Recovery From Suicidal Thinking And Treatment Resistant Mental Illness
4. Tufts receives NIH grant to study obesity prevention in new immigrants
5. New Research From EBRI: Study Examines Issues in Capping Tax Exclusion of Health Coverage
6. 2009 Most Wired Survey and Benchmarking Study Opens Today
7. Seattle Reproductive Medicine Study Investigates Newly Formulated Medications for Luteal Support in IVF
8. Newer Antipsychotics Pose Cardiac Risk: Study
9. Study uses bone marrow stem cells to regenerate skin
10. Study shows surgery provides good long-term outcomes for patients with gastrointestinal cancers
11. TPHAC Reaction to Economic Impact Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... Excel ... Mike Finnegan to the position of Executive Vice President, Sales and Marketing. Finnegan ... technology, telehealth and medical device sales leadership. He has received industry recognition for ...
(Date:6/27/2017)... Philadelphia PA and London UK (PRWEB) , ... June 27, 2017 ... ... for applying to a clinical study is whether they can trust the sponsor to ... competitive, it is vital that sponsors and CROs establish payment strategies that encourage sites ...
(Date:6/27/2017)... ... June 27, 2017 , ... Salucro, the cloud-based payment ... care industry’s hospitals and provider groups, has announced that it will now offer ... Health is a San Francisco health-finance startup that has launched a series of ...
(Date:6/27/2017)... ... June 27, 2017 , ... Building on ... efforts, Louisiana became the sixth state to pass legislation which ensures that children ... Edwards’ signature, Louisiana joins the states of Alabama, Arizona, Florida, Utah and Washington ...
(Date:6/27/2017)... California (PRWEB) , ... June 27, 2017 , ... A ... has been projected to reach a staggering $6.81 billion by the year 2024 according ... rising at a faster rate than those made from titanium. Los Angeles area clinic ...
Breaking Medicine News(10 mins):
(Date:6/12/2017)... Kineta, Inc., a biotechnology company focused on the ... President of R&D and Head of Virology Kristin Bedard has ... the Northwest and Beyond meeting sponsored by Life Science ... from 8:30-10:30 AM PDT at the Agora Conference Center in ... Bedard will be joined by other leaders in infectious disease ...
(Date:6/9/2017)... , June 9, 2017 More than ... further effort to help spread lessons learned from clinical ... International Diabetes Federation (IDF) and Eli Lilly and Company ... the second phase of the Bringing Research in Diabetes ... their commitment to helping people with diabetes effectively manage ...
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
Breaking Medicine Technology: